Elaine D Sun
CIK 1805339 · SVP, Chief Financial Officer · last filed 2026-02-10
Elaine D Sun is a SVP, Chief Financial Officer who has filed 13 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for DVAX, was dated Feb 10, 2026. Current disclosed insider exposure totals $149.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$149.8K
3
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | 0 | $15.50 | $0 | $0 | 6 | 2026-02-10 |
| RXRX | Director | 47,557 | $3.15 | $149.8K | $0 | 2 | 2025-06-23 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, Chief Financial Officer | 14,018 | — | — | $0 | 5 | 2021-04-01 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-10 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Disp (D) | −29,865 | $0 | EDGAR |
| 2025-06-23 | RXRX | Grant (A) | +11,008 | $0 | EDGAR |
| 2025-06-13 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | +5,758 | $0 | EDGAR |
| 2025-03-19 | RXRX | Grant (A) | +36,549 | $0 | EDGAR |
| 2024-05-28 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | +5,357 | $0 | EDGAR |
| 2023-05-31 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | +5,357 | $0 | EDGAR |
| 2022-05-27 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-14 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-01 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +6,137 | -$172.2K | EDGAR |
| 2021-03-02 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +7,881 | -$192.9K | EDGAR |